Patients should be aware that some products sold as semaglutide may not contain the same active ingredient as FDA-approved semaglutide products. The FDA has received reports that some compounders may be using semaglutide salts, including semaglutide sodium or semaglutide acetate
Frasier CR, Moukdar F, Patel HD, et al
Obesity is associated with increased risk for cardiovascular disease, metabolic disorders, respiratory problems, gastrointestinal disorders, endocrine disorders, and several types of cancers
Cognitive-behavioral therapy (CBT) showed consistent efficacy for binge eating, abstinence, and eating disorder psychopathology
Compounded medications can be legally prepared during shortage periods (which semaglutide has experienced intermittently) despite patent protection